By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Versartis, Inc.  

275 Shorline Drive
Suite 450
Redwood City  California  94065  U.S.A.
Phone: 650-963-8588 Fax: n/a



Start Up

Company News
Versartis, Inc. (VSAR) Initiates Phase 2/3 Trial Of VRS-317 In Japan For Children With Growth Hormone Deficiency 4/13/2015 7:50:22 AM
Versartis, Inc. (VSAR) Presents 12-Month Data For VRS-317 At Late-Breaker Session At Endocrine Society's Annual Meeting 3/9/2015 8:01:50 AM
Versartis, Inc. (VSAR) To Present At The Barclays Global Healthcare Conference 3/4/2015 8:42:14 AM
Versartis, Inc. (VSAR) To Present At The Cowen and Company 35th Annual Health Care Conference 2/24/2015 8:53:27 AM
Versartis, Inc. (VSAR) Reports Fourth Quarter And Full Year 2014 Financial Results 2/13/2015 7:57:36 AM
Versartis, Inc. (VSAR) To Present At The 2015 Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/3/2015 7:48:52 AM
Versartis, Inc. (VSAR) Announces Pricing Of Follow-On Offering 1/22/2015 7:37:38 AM
Versartis, Inc. (VSAR) Announces Proposed Offering Of Common Stock 1/20/2015 7:40:51 AM
Versartis, Inc. (VSAR) Initiates Global Phase 3 Study Of VRS-317 In Children With Growth Hormone Deficiency 1/8/2015 7:46:25 AM
Versartis, Inc. (VSAR) Announces Positive 12 Month Data For VRS-317 from Ongoing Extension Study 1/5/2015 7:27:19 AM